Literature DB >> 14621105

Fluid homeostasis in chronic obstructive lung disease.

P W de Leeuw1, A Dees.   

Abstract

Chronic obstructive pulmonary disease (COPD) often leads to massive oedema and the development of what is usually called cor pulmonale. The mechanisms by which patients with COPD retain salt and water are not completely understood. Several abnormalities have been found including reduced renal blood flow with relatively preserved glomerular filtration rate and elevated levels of renin, aldosterone, arginine vasopressin and atrial natriuretic peptide. Generally, these abnormalities worsen with the severity of COPD and are most marked during the oedematous phases. Cardiac output is remarkably normal, suggesting that "cor pulmonale" is not primarily a cardiac disorder but rather a condition of volume overload due to activation of sodium-retaining mechanisms. The stimulus for this activation could be underfilling of the arterial system (reduced effective circulating volume) secondary to a fall in total peripheral vascular resistance. The latter is caused by hypercapnia-induced dilation of the precapillary sphincters. Apparently, the massive sodium retention by the kidney is not able to restore the circulating volume and a vicious cycle ensues ultimately leading to a clinical picture which resembles right-sided heart failure. Predictably, only blockade of the effects of carbon dioxide at the level of the precapillary sphincters would be able to halt this process.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14621105     DOI: 10.1183/09031936.03.00000603a

Source DB:  PubMed          Journal:  Eur Respir J Suppl        ISSN: 0904-1850


  13 in total

1.  Influence of pulmonary hypertension on survival in advanced lung disease.

Authors:  Don Hayes; Sylvester M Black; Joseph D Tobias; Heidi M Mansour; Bryan A Whitson
Journal:  Lung       Date:  2015-02-18       Impact factor: 2.584

2.  Pulmonary Hypertension Secondary to COPD.

Authors:  Adil Shujaat; Abubakr A Bajwa; James D Cury
Journal:  Pulm Med       Date:  2012-08-29

3.  Pulmonary heart disease: The heart-lung interaction and its impact on patient phenotypes.

Authors:  Paul R Forfia; Anjali Vaidya; Susan E Wiegers
Journal:  Pulm Circ       Date:  2013-01       Impact factor: 3.017

4.  The intravascular volume effect of Ringer's lactate is below 20%: a prospective study in humans.

Authors:  Matthias Jacob; Daniel Chappell; Klaus Hofmann-Kiefer; Tobias Helfen; Anna Schuelke; Barbara Jacob; Alexander Burges; Peter Conzen; Markus Rehm
Journal:  Crit Care       Date:  2012-05-16       Impact factor: 9.097

5.  Mixed acid-base disorders, hydroelectrolyte imbalance and lactate production in hypercapnic respiratory failure: the role of noninvasive ventilation.

Authors:  Claudio Terzano; Fabio Di Stefano; Vittoria Conti; Marta Di Nicola; Gregorino Paone; Angelo Petroianni; Alberto Ricci
Journal:  PLoS One       Date:  2012-04-23       Impact factor: 3.240

Review 6.  Respiratory mechanics and ventilatory control in overlap syndrome and obesity hypoventilation.

Authors:  Johan Verbraecken; Walter T McNicholas
Journal:  Respir Res       Date:  2013-11-20

7.  High-intensity non-invasive positive pressure ventilation for stable hypercapnic COPD.

Authors:  Wolfram Windisch; Moritz Haenel; Jan H Storre; Michael Dreher
Journal:  Int J Med Sci       Date:  2009-02-27       Impact factor: 3.738

Review 8.  Pulmonary hypertension and chronic cor pulmonale in COPD.

Authors:  Adil Shujaat; Ruth Minkin; Edward Eden
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

9.  Content Validity of the Comprehensive ICF Core Set for Chronic Obstructive Pulmonary Diseases: An International Delphi Survey.

Authors:  Andrea Jobst; Inge Kirchberger; Alarcos Cieza; Gerold Stucki; Armin Stucki
Journal:  Open Respir Med J       Date:  2013-04-05

10.  Long-term non-invasive ventilation reduces readmissions in COPD patients with two or more episodes of acute hypercapnic respiratory failure.

Authors:  Kasper Linde Ankjærgaard; Sophia Liff Maibom; Jon Torgny Wilcke
Journal:  Eur Clin Respir J       Date:  2016-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.